![MindBio Therapeutics Corp](/common/images/company/CNSX_MBIO.png)
MINDBIO THERAPEUTICS BEGINS DOSING MB22001 IN PHASE 2 CLINICAL TRIAL IN WORLD FIRST TAKE-HOME MICRODOSING STUDY IN PATIENTS WITH DEPRESSION World-first take-home approvals...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.005 | 14.2857142857 | 0.035 | 0.04 | 0.035 | 36061 | 0.03838605 | CS |
4 | 0 | 0 | 0.04 | 0.05 | 0.03 | 58646 | 0.03632415 | CS |
12 | -0.02 | -33.3333333333 | 0.06 | 0.07 | 0.03 | 51031 | 0.04351205 | CS |
26 | 0.02 | 100 | 0.02 | 0.085 | 0.015 | 61390 | 0.05002731 | CS |
52 | -0.015 | -27.2727272727 | 0.055 | 0.085 | 0.015 | 54125 | 0.04486365 | CS |
156 | -0.52 | -92.8571428571 | 0.56 | 0.56 | 0.015 | 70459 | 0.06701814 | CS |
260 | -0.52 | -92.8571428571 | 0.56 | 0.56 | 0.015 | 70459 | 0.06701814 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.